Atlas Trials

Combination Study of AZD5069 and Enzalutamide.

Clinical trial NCT03177187 · TERMINATED

Trial details

NCT number
NCT03177187
Sponsor
Institute of Cancer Research, United Kingdom
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Castration Resistant Prostate Cancer
Start date
2017-11-13
Primary completion
2022-09-15
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.